COMMUNIQUÉS West-GlobeNewswire

-
Addex-Led Consortium Receives €4.85 Million Eurostars Grant to Develop Novel Allosteric Modulator to Treat Post-Traumatic Stress Disorder (PTSD)
09/07/2019 -
Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress
09/07/2019 -
IBA signs contract to install proton therapy center in Kansas, USA
09/07/2019 -
IBA signe un contrat pour l’installation d’un centre de protonthérapie au Kansas, États-Unis
09/07/2019 -
Radient Technologies Inc. Releases 2019 Year End Financial Results and Provides Corporate Update
09/07/2019 -
Stemline Therapeutics Highlights Recent Clinical and Regulatory Developments and Details Upcoming Milestones following its Annual Shareholder Meeting
08/07/2019 -
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/07/2019 -
ICU Medical CFO Announces Intention to Retire from CFO Role After Close of FY19
08/07/2019 -
Cronos Group Inc. to Hold Second Quarter 2019 Earnings Conference Call
08/07/2019 -
Adamas Announces New Employment Inducement Grant
08/07/2019 -
Medexus Pharmaceuticals Announces Operating and Financial Results for Fourth Quarter and Full Fiscal Year Ended March 31, 2019
08/07/2019 -
AzurRx BioPharma Announces R&D Update Call on Monday, July 8th at 4:30 PM ET
08/07/2019 -
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2019 Financial Results
08/07/2019 -
AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency
08/07/2019 -
Three Genesis HealthCare Centers Earn 2019 Silver National Quality Awards
08/07/2019 -
HealthEquity Announces Commencement of Proposed Offering of Common Stock
08/07/2019 -
SunGen Pharma Receives Sixth ANDA Approval from US FDA
08/07/2019 -
Genmab Announces Positive Topline Results in the Phase II GRIFFIN Study of Transplant Eligible, Newly Diagnosed Patients with Multiple Myeloma Treated with Daratumumab in Combination with Lenalidomide, Bortezomib, and Dexamethasone
08/07/2019 -
Cerner Announces New Chief Human Resources Officer
08/07/2019
Pages